A new study, by researchers at the University of Chicago, suggests that two consecutive nights of extended sleep a week can counteract the effects of reduced sleep times during the other nights of the week.
Insomnia and other sleep difficulties are estimated to impact as many as 50-60% of children and adolescents with attention-deficit/hyperactivity disorder (ADHD); however, no products indicated for the treatment of insomnia are currently approved for use in the pediatric population.
Benzodiazepine use is associated with an increased risk of Alzheimer's disease, with exposure density correlating with increased strength of association
Differences in efficacy of medications to treat primary insomnia are often based on subjective, rather than objective, outcome measures.
U.S. high schools and middle schools should start classes later in the morning to allow kids some much-needed sleep, a leading group of pediatricians is urging.
The Food and Drug Administration (FDA) has approved Belsomra (suvorexant; Merck) tablets for use as needed to treat insomnia.
Evidence for the efficacy and safety of pharmacologic interventions to treat sleep disturbances and sleepiness caused by shift work is lacking.
People who use marijuana may have trouble falling and staying asleep and feel drowsy during the day, according to new research presented at SLEEP 2014.
For young children aged 6 months-7 years, chronic sleep curtailment correlates with increased body mass index (BMI) z score in mid-childhood and with higher overall and central adiposity.